RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+49.6%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.26B
AUM Growth
+$1.26B
(+20%)
Cap. Flow
-$31.7M
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
54.98%
Holding
68
New
14
Increased
7
Reduced
27
Closed
17
Top Buys
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$72.5M |
| 2 |
Puma Biotechnology
PBYI
|
$44.4M |
| 3 |
Sarepta Therapeutics
SRPT
|
$39.3M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$39M |
| 5 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$29.3M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$56.1M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$37.8M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$26.6M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$25.1M |
| 5 |
Brookdale Senior Living
BKD
|
$23.9M |
Sector Composition
| 1 | Healthcare | 92.15% |
| 2 | Communication Services | 1.37% |
| 3 | Consumer Staples | 0.51% |
| 4 | Technology | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $112M | 8.94% | 16,658,072 -2,492,578 | -13% | -$16.8M |
|
|
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
| $96.2M | 7.65% | 1,781,470 +399,993 | +29% | +$21.6M |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $94.4M | 7.51% | 12,751,536 +1,645,090 | +15% | +$12.2M |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $73.9M | 5.88% | 2,049,985 -1,047,865 | -34% | -$37.8M |
|
|
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $72.5M | 5.76% | +545,922 | New | +$72.5M |
|
6
Incyte
INCY
$16.5B
| $56.4M | 4.48% | 597,638 +295,331 | +98% | +$27.8M |
|
7
Penumbra
PEN
$10.6B
| $51.1M | 4.07% | 672,918 -190,663 | -22% | -$14.5M |
|
8
Molina Healthcare
MOH
$9.8B
| $45.4M | 3.61% | 778,160 -67,200 | -8% | -$3.92M |
|
|
ELGX
9
DELISTED
Endologix Inc
ELGX
| $44.6M | 3.54% | 3,480,644 -482,109 | -12% | -$6.17M |
|
|
10
Puma Biotechnology
PBYI
$254M
| $44.4M | 3.53% | +662,286 | New | +$44.4M |
|
11
Atara Biotherapeutics
ATRA
$84.6M
| $43.2M | 3.44% | 2,021,617 -387,353 | -16% | -$8.29M |
|
12
Prothena Corp
PRTA
$441M
| $42.1M | 3.35% | 701,659 +214,253 | +44% | +$12.8M |
|
|
13
Sarepta Therapeutics
SRPT
$1.78B
| $39.3M | 3.13% | +640,400 | New | +$39.3M |
|
|
14
Agios Pharmaceuticals
AGIO
$2.19B
| $39M | 3.1% | +737,900 | New | +$39M |
|
15
Centene
CNC
$14.3B
| $31.1M | 2.47% | 464,077 +178,934 | +63% | +$12M |
|
|
ARIA
16
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $29.3M | 2.33% | +2,138,471 | New | +$29.3M |
|
17
Boston Scientific
BSX
$156B
| $25.5M | 2.03% | 1,072,638 -157,682 | -13% | -$3.75M |
|
|
NSTG
18
DELISTED
NanoString Technologies, Inc.
NSTG
| $24.7M | 1.97% | 1,237,435 -711,750 | -37% | -$14.2M |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $23.7M | 1.89% | 227,267 -171,104 | -43% | -$17.9M |
|
|
ISEE
20
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $23.3M | 1.85% | +505,154 | New | +$23.3M |
|
|
ALDR
21
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $23M | 1.83% | +702,539 | New | +$23M |
|
22
Wave Life Sciences
WVE
$1.53B
| $22.8M | 1.81% | 701,822 -393,651 | -36% | -$12.8M |
|
|
PTLA
23
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $20.8M | 1.66% | 916,927 -549,610 | -37% | -$12.5M |
|
|
OXFD
24
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $18M | 1.43% | 1,431,119 +3,025 | +0.2% | +$38K |
|
|
CMRX
25
DELISTED
Chimerix, Inc.
CMRX
| $17.8M | 1.42% | 3,214,946 -73,430 | -2% | -$407K |
|